ReviewJournal of hematology & oncology2021

Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.

Johannes P W Heidbuechel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.